LP(A) LEVELS IN PATIENTS UNDERGOING AORTOCORONARY BYPASS-SURGERY

被引:17
作者
AVERNA, MR
BARBAGALLO, CM
OCELLO, S
DORIA, O
DAVI, G
SCAFIDI, V
ALBIERO, R
NOTARBARTOLO, A
机构
[1] UNIV PALERMO,IST MED INTERNA & GERIATR,CATTEDRA PATOL MED,I-90134 PALERMO,ITALY
[2] OSPED CIVICO,DIV CARDIOCHIRURG,PALERMO,ITALY
关键词
AORTOCORONARY BYPASS; LIPIDS; APOPROTEINS; LP(A);
D O I
10.1093/oxfordjournals.eurheartj.a060074
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The aims of this study were to evaluate plasma lipid, apoprotein and Lp(a) levels in patients with severe coronary atherosclerosis undergoing aorto-coronary bypass surgery (BP) and to relate these parameters to the involvement of one or more vessels. Seventy-seven male patients and 77 cardiovascular disease-free controls, matched for sex, age and body weight were studied. Higher triglyceride and apo B levels with lower HDL-cholesterol and apo A-I levels were found in BP patients in comparison with the controls. Lp(a) levels were slightly, but not significantly, increased. Moreover BP patients presented a significantly higher prevalence of HDL-cholesterol levels below 35 mg dl-1 (49·3% vs 22·1%) and Lp(a) levels above 70mg dl-1 (10·4% vs 1·3%) than the controls. When patients were divided according to the number of coronary vessels involved (one, two or three), no significant difference was found, with a trend to increase in Lp(a) mean levels and in prevalence of Lp (a) levels above 30 and 70 mg dl-1 in more severely diseased patients.These results suggest that patients with severe coronary artery disease undergoing aorto-coronary bvpass surgery show low HDL-cholesterol levels with high triglyceride levels. Moreover Lp(a) levels above 70 mg dl-1 are highly associated with severe coronary vessel stenosis. © 1992 The European Society of Cardiology.
引用
收藏
页码:1405 / 1409
页数:5
相关论文
共 38 条
  • [11] THE TRIGLYCERIDE ISSUE - A VIEW FROM FRAMINGHAM
    CASTELLI, WP
    [J]. AMERICAN HEART JOURNAL, 1986, 112 (02) : 432 - 437
  • [12] QUANTITATION AND LOCALIZATION OF APOLIPOPROTEIN[A] AND APOLIPOPROTEIN-B IN CORONARY-ARTERY BYPASS VEIN GRAFTS RESECTED AT REOPERATION
    CUSHING, GL
    GAUBATZ, JW
    NAVA, ML
    BURDICK, BJ
    BOCAN, TMA
    GUYTON, JR
    WEILBAECHER, D
    DEBAKEY, ME
    LAWRIE, GM
    MORRISETT, JD
    [J]. ARTERIOSCLEROSIS, 1989, 9 (05): : 593 - 603
  • [13] ASSOCIATION OF LEVELS OF LIPOPROTEIN LP(A), PLASMA-LIPIDS, AND OTHER LIPOPROTEINS WITH CORONARY-ARTERY DISEASE DOCUMENTED BY ANGIOGRAPHY
    DAHLEN, GH
    GUYTON, JR
    ATTAR, M
    FARMER, JA
    KAUTZ, JA
    GOTTO, AM
    [J]. CIRCULATION, 1986, 74 (04) : 758 - 765
  • [14] DISCRIMINATIVE VALUE OF LIPIDS AND APOPROTEINS IN CORONARY HEART-DISEASE
    DEBACKER, G
    ROSSENEU, M
    DESLYPERE, JP
    [J]. ATHEROSCLEROSIS, 1982, 42 (2-3) : 197 - 203
  • [15] THE ASSOCIATION OF RISK-FACTORS WITH ARTERIOGRAPHICALLY DEFINED CORONARY-ARTERY DISEASE - WHAT IS THE APPROPRIATE CONTROL-GROUP
    FRIED, LP
    PEARSON, TA
    [J]. AMERICAN JOURNAL OF EPIDEMIOLOGY, 1987, 125 (05) : 844 - 853
  • [16] FRIEDEWALD WT, 1972, CLIN CHEM, V18, P499
  • [17] PREVALENCE OF LIPOPROTEIN (A) [LP(A)] EXCESS IN CORONARY-ARTERY DISEASE
    GENEST, J
    JENNER, JL
    MCNAMARA, JR
    ORDOVAS, JM
    SILBERMAN, SR
    WILSON, PWF
    SCHAEFER, EJ
    [J]. AMERICAN JOURNAL OF CARDIOLOGY, 1991, 67 (13) : 1039 - 1045
  • [18] LIPOPROTEIN LP(A) - A RISK FACTOR FOR MYOCARDIAL-INFARCTION
    HOEFLER, G
    HARNONCOURT, F
    PASCHKE, E
    MIRTL, W
    PFEIFFER, KH
    KOSTNER, GM
    [J]. ARTERIOSCLEROSIS, 1988, 8 (04): : 398 - 401
  • [19] SERUM LP(A) LEVEL AS A PREDICTOR OF VEIN GRAFT STENOSIS AFTER CORONARY-ARTERY BYPASS-SURGERY IN PATIENTS
    HOFF, HF
    BECK, GJ
    SKIBINSKI, CI
    JURGENS, G
    ONEIL, J
    KRAMER, J
    LYTLE, B
    [J]. CIRCULATION, 1988, 77 (06) : 1238 - 1244
  • [20] KANNEL WB, 1974, ANN INTERN MED, V19, P1